BSETrident Texofab LtdMediumNeutral
Announced Wed, 13 Aug · 21:21 IST

The Board of Directors inter-alia has approved the Appointment Secretarial Auditor, subject to the approval of members at the ensuring AGM

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Trident Texofab Limited held a board meeting on August 13, 2025, and approved its unaudited financial results for Q1 FY26 (quarter ended June 30, 2025). Revenue from operations rose to ₹2,807.68 lakhs from ₹2,571.21 lakhs in the same quarter last year, an increase of about 9%. Profit after tax jumped to ₹101.59 lakhs from ₹69.56 lakhs, a growth of roughly 46% year-on-year, with EPS improving to ₹0.72 from ₹0.69. The company operates in a single segment — manufacturing and wholesale trading of grey cloth. The board also approved the appointment of CS Mehul Amareliya of M/s Amareliya & Associates as Secretarial Auditor for five financial years (FY 2025-26 to FY 2029-30), subject to shareholder approval at the upcoming AGM. No investor complaints were pending during the quarter.

Likely market impact

Positive — strong profit growth (~46% YoY) on modest revenue growth signals improved margins. The secretarial auditor appointment is routine and requires AGM ratification. Minor positive for shareholders given the earnings beat.